Rita Boukamel - Accelerate Diagnostics Senior EMEA
| AXDXDelisted Stock | USD 0.04 0.02 164.90% |
Executive
Rita Boukamel is Senior EMEA of Accelerate Diagnostics
| Phone | 520 365 3100 |
| Web | https://acceleratediagnostics.com |
Accelerate Diagnostics Management Efficiency
The company has return on total asset (ROA) of (0.7366) % which means that it has lost $0.7366 on every $100 spent on assets. This is way below average. Accelerate Diagnostics' management efficiency ratios could be used to measure how well Accelerate Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities.Accelerate Diagnostics currently holds 66.58 M in liabilities with Debt to Equity (D/E) ratio of 2.76, implying the company greatly relies on financing operations through barrowing. Accelerate Diagnostics has a current ratio of 4.39, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Accelerate Diagnostics' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Dan Yarbrough | Orthofix Medical | N/A | |
| John Manders | SurModics | 43 | |
| Teryl Sides | SurModics | 55 | |
| Mark Namaroff | Anika Therapeutics | 62 | |
| Sujay Mashru | LivaNova PLC | N/A | |
| Mehul Joshi | Pulmonx Corp | 64 | |
| Reay MD | Sight Sciences | N/A | |
| Sudhakar Varshney | Avanos Medical | 47 | |
| Lee Burnes | Avanos Medical | N/A | |
| Randy Waddell | Iradimed Co | N/A | |
| Deanna Wilke | LivaNova PLC | N/A | |
| Irene Thomas | Neuropace | 55 | |
| Mira Leiwant | Anika Therapeutics | N/A | |
| Kimberly Lockwood | CONMED | N/A | |
| Florian Tyrs | Artivion | 43 | |
| Gordon Weber | SurModics | 61 | |
| Tom Huang | Sight Sciences | N/A | |
| Craig Palmer | CVRx Inc | 47 | |
| Michael CPA | Anika Therapeutics | 51 | |
| Scott Galovan | Avanos Medical | N/A | |
| Dylan John | Neuropace | N/A | |
Management Performance
| Return On Asset | -0.74 |
Accelerate Diagnostics Leadership Team
Elected by the shareholders, the Accelerate Diagnostics' board of directors comprises two types of representatives: Accelerate Diagnostics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Accelerate. The board's role is to monitor Accelerate Diagnostics' management team and ensure that shareholders' interests are well served. Accelerate Diagnostics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Accelerate Diagnostics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lawrence Mertz, Chief Officer | ||
| Michael Bridge, Gen VP | ||
| Laura Costa, VP Support | ||
| Rita Boukamel, Senior EMEA | ||
| Jack Phillips, President CEO | ||
| Maya Gowri, Senior Operations | ||
| Ron Price, Senior Vice President Head - Commercial Operations | ||
| Cherif Bousselham, VP EMEA | ||
| Chris Thode, Senior Commercial | ||
| Steve Reichling, CFO, Chief Accounting Officer and Secretary | ||
| Gretchen Strohminger, Senior Culture | ||
| John Meduri, Chief Officer | ||
| Laura Pierson, Investor Officer | ||
| David Patience, Principal CFO |
Accelerate Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Accelerate Diagnostics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.74 | |||
| Operating Margin | (2.82) % | |||
| Current Valuation | 50.42 M | |||
| Shares Outstanding | 25.29 M | |||
| Shares Owned By Insiders | 38.30 % | |||
| Shares Owned By Institutions | 17.91 % | |||
| Number Of Shares Shorted | 297.38 K | |||
| Price To Earning | (15.18) X | |||
| Price To Sales | 0.07 X | |||
| Revenue | 11.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in national income and product accounts. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Accelerate Stock
If you are still planning to invest in Accelerate Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accelerate Diagnostics' history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |